Every investor is looking for opportunities, but finding promising stocks and deciding when to buy is rarely a simple task. Successful investing often depends on separating temporary market moves from ...

Myricx is working on a new "family" of antibody-drug conjugates, which have become an important part of cancer treatment.

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...